 |
 |

Partial Uptake of Varicella Vaccine and the Epidemiological Effect on Varicella Disease in 11 Day-Care Centers in North Carolina
Dennis A. Clements, MD, PhD;
Jeffrey I. Zaref, MD;
Christine L. Bland, RN;
Emmanuel B. Walter, MD, MPH;
Paul M. Coplan, PhD
Arch Pediatr Adolesc Med. 2001;155:455-461.
Background The increasing use of varicella vaccine in children attending day care
has rapidly decreased the incidence of wild-type varicella disease. The herd
immunity noted is significant and will have an effect on the epidemiology
of natural varicella.
Objective To monitor the change in varicella incidence in day-care attendees after
the licensure of varicella vaccine.
Design A prospective observational cohort study design.
Setting Eleven private day-care centers and preschools in North Carolina participated
in the study from January 1, 1995, through December 31, 1999.
Participants All children in the 11 centers were eligible for participation. Some
participated more actively, supplying information on a regular basis. Others
participated passively. Day-care personnel provided information about all
cases of varicella.
Interventions None.
Main Outcome Variables The change in the incidence of varicella disease was documented as the
use of varicella vaccine increased.
Results Varicella vaccine coverage increased substantially from 4.4% in 1995
to 63.1% in December 1999. The vaccination rate accelerated dramatically in
1996 and 1997, leveled off in 1998, and rose again in 1999. Cumulative varicella
incidence decreased from 16.74 cases per 1000 person-months in July 1996 to
1.53 cases per 1000 person-months in December 1999 in unvaccinated children.
Conclusions The varicella vaccination rate continued to increase slowly in the day-care
population after an initial rapid uptake. The decrease in varicella disease
is greater than the increase in varicella vaccination. This herd effect is
welcome and even apparent in the unvaccinated children younger than 1 year.
From the Duke Vaccine Unit, Duke Children's Hospital, Durham, NC (Drs
Clements, Zaref, and Walter and Ms Bland); and the Merck Research Laboratories,
Blue Bell, Pa (Dr Coplan).
Corresponding author: Dennis A. Clements, MD, PhD, Campus Box 3810,
Duke University Medical Center, Durham, NC 27710 (e-mail: cleme002{at}mc.duke.edu).
RELATED ARTICLE
Herd Immunity and the Varicella Vaccine: Is It a Good Thing?
Arch Pediatr Adolesc Med. ;155():440-441.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Preventing Varicella-Zoster Disease
Hambleton and Gershon
Clin. Microbiol. Rev. 2005;18:70-80.
ABSTRACT
| FULL TEXT
Variation in Public and Private Supply of Pneumococcal Conjugate Vaccine During a Shortage
Freed et al.
JAMA 2003;289:575-578.
ABSTRACT
| FULL TEXT
Varicella Disease After Introduction of Varicella Vaccine in the United States, 1995-2000
Seward et al.
JAMA 2002;287:606-611.
ABSTRACT
| FULL TEXT
Active Immunization in the United States: Developments over the Past Decade
Dennehy
Clin. Microbiol. Rev. 2001;14:872-908.
ABSTRACT
| FULL TEXT
|